Immediate Impact
1 by Nobel laureates 2 from Science/Nature 59 standout
Citing Papers
Type 1 diabetes
2023 Standout
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
2023 Standout
Works of T Beck being referenced
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| T Beck | 159 | 60 | 261 | 146 | 5 | 382 | |
| Patricia Algara | 205 | 22 | 363 | 246 | 7 | 415 | |
| Eileen Sussman | 149 | 15 | 281 | 125 | 9 | 402 | |
| Steven Corso | 216 | 14 | 286 | 164 | 9 | 417 | |
| RM Braziel | 221 | 30 | 331 | 157 | 5 | 432 | |
| Robert Peter Gale | 158 | 18 | 139 | 69 | 12 | 372 | |
| JG Gribben | 227 | 17 | 285 | 160 | 6 | 428 | |
| Gabriela Mladonická Pavlasová | 99 | 44 | 129 | 128 | 6 | 435 | |
| RJ Lukes | 129 | 23 | 282 | 237 | 10 | 433 | |
| Björn Löfström | 46 | 20 | 193 | 80 | 8 | 376 | |
| F Rigal | 121 | 13 | 234 | 113 | 8 | 343 |
All Works
Loading papers...